Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Molecular and environmental analysis of Campania (Italy) sweet cherry (Prunus avium L.) cultivars for biocultural refugia identification and conservation.

Muccillo L, Colantuoni V, Sciarrillo R, Baiamonte G, Salerno G, Marziano M, Sabatino L, Guarino C.

Sci Rep. 2019 May 1;9(1):6796. doi: 10.1038/s41598-019-43226-2.

2.

Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists.

Sabatino L, Ziccardi P, Cerchia C, Muccillo L, Piemontese L, Loiodice F, Colantuoni V, Lupo A, Lavecchia A.

Sci Rep. 2019 Apr 1;9(1):5434. doi: 10.1038/s41598-019-41765-2.

3.

Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers.

Remo A, Manfrin E, Parcesepe P, Ferrarini A, Han HS, Mickys U, Laudanna C, Simbolo M, Malanga D, Oliveira DM, Baritono E, Colangelo T, Sabatino L, Giuliani J, Molinari E, Garonzi M, Xumerle L, Delledonne M, Giordano G, Ghimenton C, Lonardo F, D'angelo F, Grillo F, Mastracci L, Viglietto G, Ceccarelli M, Colantuoni V, Scarpa A, Pancione M.

Mol Cancer Res. 2018 Sep;16(9):1385-1395. doi: 10.1158/1541-7786.MCR-18-0062. Epub 2018 May 21.

4.

DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.

Pistore C, Giannoni E, Colangelo T, Rizzo F, Magnani E, Muccillo L, Giurato G, Mancini M, Rizzo S, Riccardi M, Sahnane N, Del Vescovo V, Kishore K, Mandruzzato M, Macchi F, Pelizzola M, Denti MA, Furlan D, Weisz A, Colantuoni V, Chiarugi P, Bonapace IM.

Oncogene. 2017 Oct 5;36(40):5551-5566. doi: 10.1038/onc.2017.159. Epub 2017 Jun 5.

PMID:
28581528
5.

Genetics of medullary thyroid cancer: An overview.

Accardo G, Conzo G, Esposito D, Gambardella C, Mazzella M, Castaldo F, Di Donna C, Polistena A, Avenia N, Colantuoni V, Giugliano D, Pasquali D.

Int J Surg. 2017 May;41 Suppl 1:S2-S6. doi: 10.1016/j.ijsu.2017.02.064. Review.

6.

Heart failure: Pilot transcriptomic analysis of cardiac tissue by RNA-sequencing.

Schiano C, Costa V, Aprile M, Grimaldi V, Maiello C, Esposito R, Soricelli A, Colantuoni V, Donatelli F, Ciccodicola A, Napoli C.

Cardiol J. 2017;24(5):539-553. doi: 10.5603/CJ.a2017.0052. Epub 2017 May 12.

7.

A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability.

Vasaturo M, Fiengo L, De Tommasi N, Sabatino L, Ziccardi P, Colantuoni V, Bruno M, Cerchia C, Novellino E, Lupo A, Lavecchia A, Piaz FD.

Sci Rep. 2017 Jan 24;7:41273. doi: 10.1038/srep41273.

8.

New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity.

Piemontese L, Cerchia C, Laghezza A, Ziccardi P, Sblano S, Tortorella P, Iacobazzi V, Infantino V, Convertini P, Dal Piaz F, Lupo A, Colantuoni V, Lavecchia A, Loiodice F.

Eur J Med Chem. 2017 Feb 15;127:379-397. doi: 10.1016/j.ejmech.2016.12.047. Epub 2016 Dec 24.

PMID:
28076827
9.

Friend or foe? The tumour microenvironment dilemma in colorectal cancer.

Colangelo T, Polcaro G, Muccillo L, D'Agostino G, Rosato V, Ziccardi P, Lupo A, Mazzoccoli G, Sabatino L, Colantuoni V.

Biochim Biophys Acta Rev Cancer. 2017 Jan;1867(1):1-18. doi: 10.1016/j.bbcan.2016.11.001. Epub 2016 Nov 16. Review.

PMID:
27864070
10.

Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.

Milone MR, Pucci B, Colangelo T, Lombardi R, Iannelli F, Colantuoni V, Sabatino L, Budillon A.

Mol Oncol. 2016 Oct;10(8):1344-62. doi: 10.1016/j.molonc.2016.07.006. Epub 2016 Jul 25.

11.

Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancer.

Mazzoccoli G, Colangelo T, Panza A, Rubino R, Tiberio C, Palumbo O, Carella M, Trombetta D, Gentile A, Tavano F, Valvano MR, Storlazzi CT, Macchia G, De Cata A, Bisceglia G, Capocefalo D, Colantuoni V, Sabatino L, Piepoli A, Mazza T.

Oncotarget. 2016 Jul 19;7(29):45444-45461. doi: 10.18632/oncotarget.9989.

12.

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

Roma C, Rachiglio AM, Pasquale R, Fenizia F, Iannaccone A, Tatangelo F, Antinolfi G, Parrella P, Graziano P, Sabatino L, Colantuoni V, Botti G, Maiello E, Normanno N.

Cancer Biol Ther. 2016 Aug 2;17(8):840-8. doi: 10.1080/15384047.2016.1195048.

13.

The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligands.

Zurlo D, Ziccardi P, Votino C, Colangelo T, Cerchia C, Dal Piaz F, Dallavalle S, Moricca S, Novellino E, Lavecchia A, Colantuoni V, Lupo A.

Biochem Pharmacol. 2016 May 15;108:22-35. doi: 10.1016/j.bcp.2016.03.007. Epub 2016 Mar 17.

PMID:
26995279
14.

Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.

Colangelo T, Polcaro G, Ziccardi P, Pucci B, Muccillo L, Galgani M, Fucci A, Milone MR, Budillon A, Santopaolo M, Votino C, Pancione M, Piepoli A, Mazzoccoli G, Binaschi M, Bigioni M, Maggi CA, Fassan M, Laudanna C, Matarese G, Sabatino L, Colantuoni V.

Cell Death Dis. 2016 Feb 25;7:e2120. doi: 10.1038/cddis.2016.28.

15.

The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells.

Colangelo T, Polcaro G, Ziccardi P, Muccillo L, Galgani M, Pucci B, Milone MR, Budillon A, Santopaolo M, Mazzoccoli G, Matarese G, Sabatino L, Colantuoni V.

Cell Death Dis. 2016 Feb 25;7:e2108. doi: 10.1038/cddis.2016.29.

16.

Deregulated expression of cryptochrome genes in human colorectal cancer.

Mazzoccoli G, Colangelo T, Panza A, Rubino R, De Cata A, Tiberio C, Valvano MR, Pazienza V, Merla G, Augello B, Trombetta D, Storlazzi CT, Macchia G, Gentile A, Tavano F, Vinciguerra M, Bisceglia G, Rosato V, Colantuoni V, Sabatino L, Piepoli A.

Mol Cancer. 2016 Jan 15;15:6. doi: 10.1186/s12943-016-0492-8.

17.

A Timeless Link Between Circadian Patterns and Disease.

Mazzoccoli G, Laukkanen MO, Vinciguerra M, Colangelo T, Colantuoni V.

Trends Mol Med. 2016 Jan;22(1):68-81. doi: 10.1016/j.molmed.2015.11.007. Epub 2015 Dec 13. Review.

PMID:
26691298
18.

Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.

Remo A, Simeone I, Pancione M, Parcesepe P, Finetti P, Cerulo L, Bensmail H, Birnbaum D, Van Laere SJ, Colantuoni V, Bonetti F, Bertucci F, Manfrin E, Ceccarelli M.

J Transl Med. 2015 May 1;13:138. doi: 10.1186/s12967-015-0492-2.

19.

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

Circelli L, Ramundo V, Marotta V, Sciammarella C, Marciello F, Del Prete M, Sabatino L, Pasquali D, Izzo F, Scala S, Colao A, Faggiano A, Colantuoni V; Multidisciplinary Group for NeuroEndocrine Tumours of Naples.

J Cell Mol Med. 2015 Jul;19(7):1735-41. doi: 10.1111/jcmm.12552. Epub 2015 Mar 30.

20.

A novel reliable method of DNA extraction from olive oil suitable for molecular traceability.

Raieta K, Muccillo L, Colantuoni V.

Food Chem. 2015 Apr 1;172:596-602. doi: 10.1016/j.foodchem.2014.09.101. Epub 2014 Sep 28.

PMID:
25442596
21.

Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.

Sabatino L, Pancione M, Votino C, Colangelo T, Lupo A, Novellino E, Lavecchia A, Colantuoni V.

World J Gastroenterol. 2014 Jun 21;20(23):7137-51. doi: 10.3748/wjg.v20.i23.7137. Review.

22.

Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis.

Pancione M, Giordano G, Remo A, Febbraro A, Sabatino L, Manfrin E, Ceccarelli M, Colantuoni V.

J Immunol Res. 2014;2014:686879. doi: 10.1155/2014/686879. Epub 2014 Jan 16. Review.

23.

Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.

Zurlo D, Assante G, Moricca S, Colantuoni V, Lupo A.

Biochim Biophys Acta. 2014 Jul;1840(7):2361-72. doi: 10.1016/j.bbagen.2014.04.007. Epub 2014 Apr 13.

PMID:
24735796
24.

Current concepts of pheochromocytoma.

Conzo G, Pasquali D, Colantuoni V, Circelli L, Tartaglia E, Gambardella C, Napolitano S, Mauriello C, Avenia N, Santini L, Sinisi AA.

Int J Surg. 2014;12(5):469-74. doi: 10.1016/j.ijsu.2014.04.001. Epub 2014 Apr 12. Review.

25.

A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides.

Ferrara G, Pancione M, Votino C, Quaglino P, Tomasini C, Santucci M, Pimpinelli N, Cusano F, Sabatino L, Colantuoni V.

Br J Dermatol. 2014 Jun;170(6):1266-75. doi: 10.1111/bjd.12717. Epub 2014 Jun 6.

PMID:
24641245
26.

Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.

Panza A, Votino C, Gentile A, Valvano MR, Colangelo T, Pancione M, Micale L, Merla G, Andriulli A, Sabatino L, Vinciguerra M, Prattichizzo C, Mazzoccoli G, Colantuoni V, Piepoli A.

Biochim Biophys Acta. 2014 Jun;1843(6):1225-36. doi: 10.1016/j.bbamcr.2014.03.003. Epub 2014 Mar 11.

27.

Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours.

Ramundo V, Del Prete M, Marotta V, Marciello F, Camera L, Napolitano V, De Luca L, Circelli L, Colantuoni V, Di Sarno A, Carratù AC, de Luca di Roseto C, Colao A, Faggiano A; Multidisciplinary Group for Neuroendocrine Tumors of Naples.

Clin Endocrinol (Oxf). 2014 Jun;80(6):850-5. doi: 10.1111/cen.12411. Epub 2014 Feb 19.

PMID:
24443791
28.

The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.

Pancione M, Remo A, Zanella C, Sabatino L, Di Blasi A, Laudanna C, Astati L, Rocco M, Bifano D, Piacentini P, Pavan L, Purgato A, Greco F, Talamini A, Bonetti A, Ceccarelli M, Vendraminelli R, Manfrin E, Colantuoni V.

J Transl Med. 2013 Nov 28;11:297. doi: 10.1186/1479-5876-11-297.

29.

Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling.

Pagnotta SM, Laudanna C, Pancione M, Sabatino L, Votino C, Remo A, Cerulo L, Zoppoli P, Manfrin E, Colantuoni V, Ceccarelli M.

PLoS One. 2013 Aug 19;8(8):e72638. doi: 10.1371/journal.pone.0072638. eCollection 2013.

30.

Biochemical features of native red wines and genetic diversity of the corresponding grape varieties from Campania region.

Muccillo L, Gambuti A, Frusciante L, Iorizzo M, Moio L, Raieta K, Rinaldi A, Colantuoni V, Aversano R.

Food Chem. 2014 Jan 15;143:506-13. doi: 10.1016/j.foodchem.2013.07.133. Epub 2013 Aug 8.

PMID:
24054274
31.

MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.

Colangelo T, Fucci A, Votino C, Sabatino L, Pancione M, Laudanna C, Binaschi M, Bigioni M, Maggi CA, Parente D, Forte N, Colantuoni V.

Neoplasia. 2013 Sep;15(9):1086-99.

32.

Right-sided rhabdoid colorectal tumors might be related to the serrated pathway.

Pancione M, Remo A, Sabatino L, Zanella C, Votino C, Fucci A, Di Blasi A, Lepore G, Daniele B, Fenizia F, Molinari E, Normanno N, Manfrin E, Vendraminelli R, Colantuoni V.

Diagn Pathol. 2013 Feb 20;8:31. doi: 10.1186/1746-1596-8-31.

33.

Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series.

Conzo G, Musella M, Corcione F, De Palma M, Ferraro F, Palazzo A, Napolitano S, Milone M, Pasquali D, Sinisi AA, Colantuoni V, Santini L.

Int J Surg. 2013;11(2):152-6. doi: 10.1016/j.ijsu.2012.12.007. Epub 2012 Dec 23.

34.

Multiple endocrine neoplasia, the old and the new: a mini review.

Pasquali D, Di Matteo FM, Renzullo A, Accardo G, Esposito D, Barbato F, Colantuoni V, Circelli L, Conzo G.

G Chir. 2012 Nov-Dec;33(11-12):370-3. Review.

PMID:
23140918
35.

Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.

Simmer F, Brinkman AB, Assenov Y, Matarese F, Kaan A, Sabatino L, Villanueva A, Huertas D, Esteller M, Lengauer T, Bock C, Colantuoni V, Altucci L, Stunnenberg HG.

Epigenetics. 2012 Dec 1;7(12):1355-67. doi: 10.4161/epi.22562. Epub 2012 Oct 18.

36.

The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer.

Fucci A, Colangelo T, Votino C, Pancione M, Sabatino L, Colantuoni V.

PPAR Res. 2012;2012:242498. Epub 2012 Sep 6.

37.

Genetic and epigenetic events generate multiple pathways in colorectal cancer progression.

Pancione M, Remo A, Colantuoni V.

Patholog Res Int. 2012;2012:509348. doi: 10.1155/2012/509348. Epub 2012 Jul 24.

38.

PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.

Sabatino L, Fucci A, Pancione M, Colantuoni V.

PPAR Res. 2012;2012:687492. doi: 10.1155/2012/687492. Epub 2012 Jul 16.

39.

Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene.

Conzo G, Circelli L, Pasquali D, Sinisi A, Sabatino L, Accardo G, Renzullo A, Santini L, Salvatore F, Colantuoni V.

Clin Endocrinol (Oxf). 2012 Dec;77(6):934-6. doi: 10.1111/j.1365-2265.2012.04412.x. No abstract available.

PMID:
22500673
40.

UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.

Sabatino L, Fucci A, Pancione M, Carafa V, Nebbioso A, Pistore C, Babbio F, Votino C, Laudanna C, Ceccarelli M, Altucci L, Bonapace IM, Colantuoni V.

Oncogene. 2012 Dec 6;31(49):5061-72. doi: 10.1038/onc.2012.3. Epub 2012 Jan 30.

PMID:
22286757
41.

Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells.

Zurlo D, Leone C, Assante G, Salzano S, Renzone G, Scaloni A, Foresta C, Colantuoni V, Lupo A.

Mol Carcinog. 2013 Jan;52(1):1-17. doi: 10.1002/mc.20872. Epub 2011 Oct 24.

42.

A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation.

Pancione M, Di Blasi A, Sabatino L, Fucci A, Dalena AM, Palombi N, Carotenuto P, Aquino G, Daniele B, Normanno N, Colantuoni V.

Hum Pathol. 2011 Jul;42(7):1047-52. doi: 10.1016/j.humpath.2010.10.016. Epub 2011 Feb 11.

PMID:
21315413
43.

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

Pasquali D, Circelli L, Faggiano A, Pancione M, Renzullo A, Elisei R, Romei C, Accardo G, Coppola VR, De Palma M, Ferolla P, Grimaldi F, Colao A, Colantuoni V.

Eur J Endocrinol. 2011 Mar;164(3):397-404. doi: 10.1530/EJE-10-0929. Epub 2010 Dec 21.

PMID:
21177330
44.

Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.

Pancione M, Sabatino L, Fucci A, Carafa V, Nebbioso A, Forte N, Febbraro A, Parente D, Ambrosino C, Normanno N, Altucci L, Colantuoni V.

PLoS One. 2010 Dec 3;5(12):e14229. doi: 10.1371/journal.pone.0014229. Erratum in: PLoS One. 2011;6(1). doi: 10.1371/annotation/07419a37-33f1-4e4a-adc9-b186f305bae5.

45.

The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.

Pancione M, Forte N, Campione S, Napolitano A, Parente D, Sabatino L, Febbraro A, Colantuoni V.

Pathologica. 2010 Apr;102(2):51-6.

PMID:
23596757
46.

Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.

Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, Di Blasi A, Daniele B, Parente D, Colantuoni V.

Hum Pathol. 2010 Jun;41(6):867-76. doi: 10.1016/j.humpath.2009.09.019. Epub 2010 Feb 4.

PMID:
20129645
47.

A novel germline mutation in peroxisome proliferator-activated receptor gamma gene associated with large intestine polyp formation and dyslipidemia.

Capaccio D, Ciccodicola A, Sabatino L, Casamassimi A, Pancione M, Fucci A, Febbraro A, Merlino A, Graziano G, Colantuoni V.

Biochim Biophys Acta. 2010 Jun;1802(6):572-81. doi: 10.1016/j.bbadis.2010.01.012. Epub 2010 Feb 1.

48.

The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis.

Chiefari E, Paonessa F, Iiritano S, Le Pera I, Palmieri D, Brunetti G, Lupo A, Colantuoni V, Foti D, Gulletta E, De Sarro G, Fusco A, Brunetti A.

BMC Biol. 2009 May 21;7:24. doi: 10.1186/1741-7007-7-24.

49.

Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1).

Bianconcini A, Lupo A, Capone S, Quadro L, Monti M, Zurlo D, Fucci A, Sabatino L, Brunetti A, Chiefari E, Gottesman ME, Blaner WS, Colantuoni V.

Int J Biochem Cell Biol. 2009 Nov;41(11):2189-203. doi: 10.1016/j.biocel.2009.04.011. Epub 2009 Apr 21.

50.

Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.

Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, Febbraro A, Colantuoni V.

Hum Pathol. 2009 May;40(5):714-25. doi: 10.1016/j.humpath.2008.08.019. Epub 2009 Jan 3.

PMID:
19121846

Supplemental Content

Loading ...
Support Center